MUC1 expression in human prostate cancer cell lines and primary tumors

Prostate Cancer and Prostatic Diseases

Volumn 8, Issue 1, 2005, Pages 36-44

  O'Connor, J C ^a   Julian, J ^a   Lim, S D ^b   Carson, D D ^a  

^a UNIVERSITY OF DELAWARE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

MUC1; Mucin; Prostate cancer

Indexed keywords

ANDROSTANOLONE; CORE PROTEIN; GAMMA INTERFERON; ISOPROTEIN; MONOCLONAL ANTIBODY; MUCIN 1; TUMOR NECROSIS FACTOR ALPHA; CA 15-3 ANTIGEN; CYTOKINE;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE ASSOCIATION; DISEASE EXACERBATION; GLEASON SCORE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; TISSUE MICROARRAY; BIOSYNTHESIS; CANCER STAGING; CELL CULTURE; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; PATHOLOGY; PROSTATE TUMOR; WESTERN BLOTTING;

BLOTTING, WESTERN; CA-15-3 ANTIGEN; CYTOKINES; DIHYDROTESTOSTERONE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 20444453686     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500762     Document Type: Article

References (39)

1. Gendler SJ. MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia 2001; 6: 339-353.
2. Gendler SJ, Spicer AP. Epithelial mucin genes. Annu Rev Physiol 1995; 57: 607-634.
3. Lagow E, DeSouza MM, Carson DD. Mammalian reproductive tract mucins. Hum Reprod Update 1999; 5: 280-292.
4. Taylor-Papadimitriou J et al. MUC1 and cancer. Biochim Biophys Acta 1999; 1455: 301-313.
5. Yamamoto M et al. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and b-catenin in cell adhesion. J Biol Chem 1997; 272: 12492-12494.
6. Pandey P, Kharbanda S, Kufe D. Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein. Cancer Res 1995; 55: 4000-4003.
7. Li Y et al. Interaction of glycogen synthase kinase 3b with the DF3/MUC1 carcinoma-associated antigen and β-catenin. Mol Cell Biol 1998; 18: 7216-7224.
8. Ho SB et al. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 1993; 53: 641-651.
9. Zotter S et al. Tissue and tumour distribution of human polymorphic epithelial mucin. Cancer Rev 1988; 11-12: 55-101.
10. Girling A et al. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer 1989; 43: 1072-1076.
11. Burdick MD et al. Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines. J Biol Chem 1997; 272: 24198-24202.
12. Zhang S et al. Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers. Clin Cancer Res 1998; 4: 295-302.
13. Kirschenbaum A et al. MUC1 expression in prostate carcinoma: Correlation with grade and stage. Mol Urol 1999; 3: 163-167.
14. Ng YK et al. Prognostic significance of increased immunodetectable MUC-1 in prostate cancer. Proc Amer Assoc Cancer Res 1997; 38: 542.
15. Schut IC et al. MUC1 expression, splice variant and short form transcription (MUC1/Z, MUC1/Y) in prostate cell lines and tissue. BJU Int 2003; 91: 278-283.
16. Papadopoulos I et al. Tumor angiogenesis is associated with MUC1 overexpression and loss of prostate-specific antigen expression in prostate cancer. Clin Cancer Res 2001; 7: 1533-1538.
17. Devine PL et al. Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon, and prostate. A blind trial with 420 patients. Cancer 1993; 72: 2007-2015.
18. Lagow EL, Carson DD. Synergistic stimulation of MUC1 expression in normal breast epithelia and breast cancer cells by interferon-γ and tumor necrosis factor-α. J Cell Biochem 2002; 86: 759-772.
19. Lowry OH et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
20. Desai NN et al. Novel human endometrial cell line promotes blastocyst development. Fertil Steril 1994; 61: 760-766.
21. Thathiah A, Carson DD. Mucins and blastocyst attachment. Rev Endocr Metab Disord 2002; 3: 87-96.
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
23. Porzio MA, Pearson AM. Improved resolution of myofibrillar proteins with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochim Biophys Acta 1977; 490: 27-34.
24. Wesseling J et al. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 1995; 129: 255-265.
25. Surveyor GA et al. Expression and steroid hormonal control of Muc-1 in the mouse uterus. Endocrinology 1995; 136: 3639-3647.
26. Gaemers IC et al. A stat-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells. J Biol Chem 2001; 276: 6191-6199.
27. Zhang K et al. Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells. J Cell Biochem 1996; 60: 538-549.
28. Mitchell S et al. Phenotypic and genotypic characterization of commonly used human prostatic cell lines. BJU Int 2000; 85: 932-944.
29. Zhau HE, Li CL, Chung LW. Establishment of human prostate carcinoma skeletal metastasis models. Cancer 2000; 88: 2995-3001.
30. Hyytinen ER et al. Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model. Br J Cancer 1997; 75: 190-195.
31. Evangelou A et al. Androgen modulation of adhesion and antiadhesion molecules in PC-3 prostate cancer cells expressing androgen receptor. Endocrinology 2002; 143: 3897-3904.
32. Mitchell S et al. Androgen-dependent regulation of human MUC1 mucin expression. Neoplasia 2002; 4: 9-18.
33. Imai M et al. The effect of dexamethasone on human mucin 1 expression and antibody-dependent complement sensitivity in a prostate cancer cell line in vitro and in vivo. Immunology 2004; 111: 291-297.
34. Mitchell S et al. Androgen-dependent regulation of human MUC1 mucin expression. Neoplasia 2002; 4: 9-18.
35. Legrier ME et al. Mucinous differentiation features associated with hormonal escape in a human prostate cancer xenograft. Br J Cancer 2004; 90: 720-727.
36. Burke P et al. MUC1 epitope selection for prostate cancer targeted therapies. in Proc Amer Assoc Cancer Res 2003; 44: 1352.
37. Julian J, Carson DD. Formation of MUC1 metabolic complex is conserved in tumor-derived and normal epithelial cells. Biochem Biophys Res Commun 2002; 293: 1183-1190.
38. Lapointe J et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA 2004; 101: 811-816.
39. Thathiah A et al. TNFα stimulates MUC1 synthesis and ectodomain release in a human uterine epithelial cell line. Endocrinology 2004; 145: 4192-4203.